IP Library Granted Patent US 10,316,323
Granted Patent B2
US 10,316,323 · App. 15/679,312 · Granted Jun 11, 2019

Microorganisms engineered to use unconventional sources of nitrogen

Inventors: Colin South (Lexington, MA); Arthur J Shaw, IV (Belmont, MA)
Assignee: Novogy, Inc.
C12N15/815C12N1/20C12N9/14C12N9/88C12N15/70C12N15/81C12P3/00C12Y308/01C12Y402/01069
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,316,323
App. No.
15/679,312
Granted
Jun 11, 2019
Kind
B2
Abstract

Disclosed are genetically engineered organisms, such as yeast and bacteria, that have the ability to metabolize atypical nitrogen sources, such as melamine and cyanamide. Fermentation methods using the genetically engineered organisms are also described. The methods of the invention are robust processes for the industrial bioproduction of a variety of compounds, including commodities, fine chemicals, and pharmaceuticals.

Claims (15)

1. A fermentation method of culturing a genetically engineered microbial a cell comprising:

providing a cell comprising a non-native nucleic acid molecule encoding a melamine deaminase enzyme:

contacting the cell with a substrate, wherein the substrate comprises a nitrogen-containing fraction and a non-nitrogen-containing fraction and wherein the nitrogen-containing fraction comprises, in an amount from about 10% by weight to about 100% by weight, a nitrogen-containing compound of Formula I, or a salt thereof; and

culturing the cell, wherein the cell can, unlike a cell of the same species that lacks the nucleic acid molecule, metabolize the nitrogen-containing compound and wherein,

the compound of formula I is

wherein, independently for each occurrence,

is a five-, or a six-membered aryl or heteroaryl group;

R is —OH, —CO 2 H, —NO 2 , —CN, substituted or unsubstituted amino, or substituted or unsubstituted alkyl; and

n is 0, 1, 2, 3, 4, or 5.

2. The method of claim 1 , wherein the nitrogen-containing compound is selected from the group consisting of 5-Aminotetrazole, Melamine, Ammeline, and Ammelide.

3. The method of claim 1 , wherein the substrate does not comprise an antibiotic.

4. The method claim 1 , wherein the substrate does not comprise ammonium or urea.

5. The method of claim 1 , wherein the substrate comprises lignocellulosic material, glucose, xylose, sucrose, acetic acid, formic acid, lactic acid, butyric acid, a free fatty acid, dextrose, glycerol, fructose, lactose, galactose, mannose, rhamnose, or arabinose, or a combination thereof.

6. The method of claim 1 , wherein the genetically engineered cell is contacted with the substrate in a fermentor.

7. The method of claim 1 , wherein the non-native nucleic acid molecule comprises SEQ ID NO: 12 or SEQ ID NO: 13 or the non-native molecule comprises a sequence having at least 85% sequence identity with SEQ ID NO:12 or SEQ ID NO:13.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2021
From: SOUTH, COLIN R.; SHAW, ARTHUR J.
To: NOVOGY, INC.
Reel/Frame 055544/0095 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 054142 FRAME: 0171. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Nov 17, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 054451/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC
Reel/Frame 054142/0171 →
Continuity (4)
Division 14759878
Provisional Application 61782351 · Mar 14, 2013
Provisional Application 61748901 · Jan 4, 2013
Related Publication 20180051294A1 · Feb 22, 2018